Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Hyperplasia collateral-activating pill for treating knee osteoarthritis

A technology of osteoarthritis and life luo pills, applied in the field of traditional Chinese medicine, can solve the problems of high surgical risk, slow healing, and patient pain.

Active Publication Date: 2013-01-02
郑州中医骨伤病医院
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] 2. There is a snapping sound when the joint is moved;
However, the current existing drug therapy or surgical treatment has disadvantages such as high surgical risk, high price, patient pain, and slow healing, which often leads to the defect of treating the symptoms but not the root cause.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0066] Zengshengluo Pills for the treatment of knee osteoarthritis of the present invention are expressed in parts by weight. Said Zengshengluo Pills are composed of 60g of raw materials Panax notoginseng, 60g of Angelica sinensis, 74g of Clematis clematis, 62g of Dipsacus, 60g of vinegar corydalis, and wine cornus 55g, Radix Paeoniae Rubra 48g, Heliconia chinensis 60g, Zhichuan Aconitum 48g, Heifengteng 60g, Wood Beetle 55g, Myrrh 58g, Gentiana 68g, Asarum 22g, Zhilicorice 48g and Zhicaowu 48g.

Embodiment 2

[0068] Zengshengluo pills for the treatment of knee osteoarthritis of the present invention are expressed in parts by weight. The Zengshengluo pills are composed of 50g of raw materials Panax notoginseng, 50g of angelica, 60g of Clematis clematis, 55g of Dipsacus, 55g of vinegar corydalis, and wine cornus 45g, Radix Paeoniae Rubra 45g, Heliconia chinensis 55g, Zhichuan Aconitum 45g, Heifengteng 55g, Wood Beetle 50g, Myrrh 55g, Gentiana 55g, Asarum 20g, Zhilicorice 45g and Zhicaowu 45g.

Embodiment 3

[0070] Zengshengluo Pills for the treatment of knee osteoarthritis of the present invention are expressed in parts by weight. Said Zengshengluo Pills are composed of 65g of raw materials Panax notoginseng, 65g of Angelica sinensis, 80g of Clematis clematis, 65g of Dipsacus, 75g of vinegar corydalis, and wine cornus 65g, Radix Paeoniae Rubra 65g, Heliconia chinensis 70g, Zhichuan Aconitum 60g, Heiferia 70g, Wood Beetle 65g, Myrrh 65g, Gentiana 70g, Asarum 40g, Zhilicorice 60g and Zhicaowu 60g.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a hyperplasia collateral-activating pill for treating knee osteoarthritis. The hyperplasia collateral-activating pill is prepared by the following active pharmaceutical ingredients by weight: 50-65 parts of pseudo-ginseng, 50-65 parts of angelica sinensis, 60-80 parts of clematis roots, 55-65 parts of teasel roots, 55-75 parts of vinegar rhizoma corydalis, 45-65 parts of wine cornus, 45-65 parts of roots of common peony, 55-70 parts of herba siegesbeckiae, 45-60 parts of radix aconiti preparata, 55-70 parts of fissistigma polyanthum, 50-65 parts of ground beeltle, 55-65 parts of myrrh, 55-70 parts of roots of large-leaved gentian, 20-40 parts of manchurian wild ginger, 45-60 parts of honey-fried licorice roots and 45-60 parts of prepared kusnezoff monkshood roots. When the hyperplasia collateral-activating pill is applied to clinical treatment, diagnosis and treatment based on an overall analysis of the illness and the conditions of patients can be achieved, and the knee osteoarthritis can be treated according to etiological factors. After the patients take the hyperplasia collateral-activating pill for ten days, clinical symptoms of the patients are reduced, pain is alleviated, treatment time of patients is effectively shortened, curative effect is obvious, and the total efficiency is as high as 95%.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a Zengshengluo pill for treating knee osteoarthritis. Background technique [0002] Osteoarthritis of the knee joint is a chronic joint disease characterized by degeneration and destruction of articular cartilage and hyperosteogeny, also known as proliferative knee arthritis and senile knee arthritis. It is a chronic joint disease, and its main changes are the degeneration of the cartilage surface of the knee joint and secondary bone hyperplasia. The main manifestations are joint pain and inflexibility. X-rays show that the joint space is narrowed, the subchondral bone is dense, the trabecular bone is broken, and there are sclerosis and cystic degeneration. Lip-like hyperplasia at the joint margin. In the late stage, the bone end deforms and the articular surface is uneven. The cartilage in the joint peels off, and the bone fragments enter the joint, form...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/716A61P19/02A61K35/64
Inventor 郭永昌李健陈春香梁艳梅郭华璋
Owner 郑州中医骨伤病医院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products